New Retina Radio by Eyetube

191 Episoder

1. New Retina Radio Journal Club w/ VBS: Risk Factors for Switching from Bevacizumab to Aflibercept in Protocol AC

   Publisert: 19.7.2024
2. From Trials to the Clinic: Using a Therapy With a Novel MOA to Treat Patients With DME

   Publisert: 11.7.2024
3. New Retina Radio Journal Club w/ VBS: RVOs During the COVID Pandemic

   Publisert: 27.6.2024
4. A Treatment With a Novel MOA for Patients With nAMD and DME: Perspectives From the Real World

   Publisert: 20.6.2024
5. AMD and DME Applications in the Retina Practice: Real-world Data

   Publisert: 17.6.2024
6. ARVO 2024 Coverage: UWF Leakage in Protocol AA, Machine Learning, and GA's Link to Anxiety/Depression

   Publisert: 5.6.2024
7. New Retina Radio Journal Club with VBS: New Retina Radio Journal Club with VBS: Is Buckling Effective for RRD in Patients at Risk for PVR?

   Publisert: 29.5.2024
8. ARVO 2024 Coverage: ≥20-week Dosing in PULSAR and TENAYA/LUCERNE

   Publisert: 17.5.2024
9. GA Options in Clinical Therapy, Part 2: Real-world Cases in GA

   Publisert: 10.5.2024
10. GA Options in Clinical Therapy, Part 1: Patient Selection and Treatment Strategies

    Publisert: 10.5.2024
11. AMD and DME Applications in the Retina Practice: RCT Comparison

    Publisert: 8.5.2024
12. The State of Biosimilars: Integration of Biosimilars into a Retina Practice

    Publisert: 25.4.2024
13. New Retina Radio Journal Club with VBS: Comparison of Antiseptics Use for IVT

    Publisert: 19.4.2024
14. Successful Management of Vitreous Opacities

    Publisert: 2.4.2024
15. New Retina Radio Journal Club with VBS: Visual Outcomes Following Surgical RRD Repair Relative to Foveal Status and Time of Surgery

    Publisert: 28.3.2024
16. The State of Biosimilars: How We Got Here and What It Means for Practice

    Publisert: 22.2.2024
17. Cherchez la Femme Revisited

    Publisert: 16.2.2024
18. AAO ’23: Downward Trends in Reimbursement and ChatGPT in the Retina Clinic

    Publisert: 14.12.2023
19. New Retina Radio Journal Club: Intentional Suspension of Therapy in Wet AMD

    Publisert: 7.12.2023
20. AAO ’23: Real-World Faricimab Patterns and Improving GA Assessments

    Publisert: 30.11.2023